Sign up to save your podcasts
Or
Share Vaccine in Sight, What Now for Stocks?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Vaccine in Sight, What Now for Stocks?
Pfizer’s Covid Vaccine shows to be more than 90% effective in clinical trials, Scott Wapner and the Investment Committee discuss the stunning news as the market soars to record highs. Is it time to buy the ‘reopening’ stocks and sell the high-flying ‘stay-at-home’ stocks?
View all episodes
By CNBC
4.5
328328 ratings
Pfizer’s Covid Vaccine shows to be more than 90% effective in clinical trials, Scott Wapner and the Investment Committee discuss the stunning news as the market soars to record highs. Is it time to buy the ‘reopening’ stocks and sell the high-flying ‘stay-at-home’ stocks?
More shows like Halftime Report
View all
Mad Money w/ Jim Cramer
4,081 Listeners
CNBC's "Fast Money"
1,355 Listeners
CNBC's "Options Action"
239 Listeners
Your Money Minute
148 Listeners
The Exchange
328 Listeners
Zacks Market Edge
296 Listeners
Fortt Knox
68 Listeners
Strange Success with Jane Wells
153 Listeners
American Greed Podcast
2,137 Listeners
Investing With IBD
383 Listeners
The Compound and Friends
2,046 Listeners
Squawk on the Street
598 Listeners
Squawk Pod
543 Listeners
The Keynote by CNBC Events
20 Listeners
CNBC's "Last Call"
302 Listeners
Worldwide Exchange
117 Listeners
Ask The Compound
307 Listeners
RiskReversal Pod
792 Listeners
MRKT Matrix
178 Listeners
TechCheck
60 Listeners
Closing Bell
161 Listeners
Power Lunch
21 Listeners
Manifest Space with Morgan Brennan
33 Listeners
CNBC’s “Money Movers”
11 Listeners
CNBC Business News Update
9 Listeners
The Crimes of Putin’s Trader
261 Listeners
CNBC Sport
9 Listeners